EUVIMEDEUVIMED entdecken
Open Access

Smartphone‐Enabled Point‐of‐Care Biosensing Platform With Self‐Calibration for Rapid Matrix‐Resistant Detection of Multiple AMI Biomarkers in Whole Blood

Beibei Lu, Huaibin Gong, Hua Huang, Kuaifa Fang, Kun Yu, Bitao Lu, Guangqian Lan

Advanced Healthcare Materials · 2026-08 · 15 (30)

DOI: 10.1002/adhm.71408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 03.07.2026. Verfasst von Beibei Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Resource Insects, College of Sericulture, Textile and Biomass Sciences, Southwest University, Chongqing, China. Hauptthemen laut MEDLINE: Smartphone, Myocardial Infarction, Biosensing Techniques, Biomarkers. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Sichuan Science and Technology Program, Natural Science Foundation of Chongqing, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myocardial infarction (AMI) requires rapid diagnosis beyond conventional methods, which suffer from biological interference and complexity, limiting point‐of‐care (POC) application. To tackle these issues, we have devised an anthraquinone (AQ)‐calibrated sensor unit coupled with smartphone‐based analysis for universal detection of AMI biomarkers in untreated whole blood. Our novel dual‐channel biosensing platform integrates AQ as an intrinsic reference standard, establishing a self‐correction mechanism to effectively counteract hematological matrix influences. The platform enables swift quantification at pg/mL levels within 5 min without sample preprocessing, achieving detection limits of 0.3, 19.7, and 0.7 pg/mL for cTnI, Mb, and CK‑MB, respectively. The smartphone‑based intelligent analyzer automates real‐time signal processing, creating a closed‐loop POC diagnostic setup that shows promise for future at‑home AMI risk monitoring. This technological breakthrough showcases notable resilience to biological matrix interference while upholding analytical sensitivity comparable to clinical standards, representing a significant step toward decentralized cardiovascular emergency management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SmartphoneMyocardial InfarctionBiosensing TechniquesBiomarkersPoint-of-Care SystemsHumansCalibrationTroponin IRapid Diagnostic TestsAnthraquinonesCreatine Kinase, MB FormLimit of Detection

Stichwörter der Autor:innen

acute myocardial infarctionanthraquinone calibrationaptamerelectrochemical biosensormatrix effect

Substanzen

BiomarkersTroponin IAnthraquinonesCreatine Kinase, MB Form

Autor:innen und Institutionen

  • State Key Laboratory of Resource Insects, College of Sericulture, Textile and Biomass Sciences, Southwest University, Chongqing, China.
  • College of Pharmaceutical Sciences, Southwest University, Chongqing, China.
  • College of Engineering and Technology, Southwest University, Chongqing, China.
  • Department of Cardiology, The Sixth People's Hospital of Huizhou, Guangdong, China.

Förderung

  • Sichuan Science and Technology Program
  • Natural Science Foundation of Chongqing, China

Zitieren

APA

Lu, B., Gong, H., Huang, H., Fang, K., Yu, K., Lu, B., & Lan, G. (2026). Smartphone‐Enabled Point‐of‐Care Biosensing Platform With Self‐Calibration for Rapid Matrix‐Resistant Detection of Multiple AMI Biomarkers in Whole Blood. Advanced Healthcare Materials, 15(30). https://doi.org/10.1002/adhm.71408

Vancouver

Lu B, Gong H, Huang H, Fang K, Yu K, Lu B, et al. Smartphone‐Enabled Point‐of‐Care Biosensing Platform With Self‐Calibration for Rapid Matrix‐Resistant Detection of Multiple AMI Biomarkers in Whole Blood. Advanced Healthcare Materials. 2026;15(30). doi:10.1002/adhm.71408

BibTeX
@article{Lu2026,
  author = {Lu, Beibei and Gong, Huaibin and Huang, Hua and Fang, Kuaifa and Yu, Kun and Lu, Bitao and Lan, Guangqian},
  title = {Smartphone‐Enabled Point‐of‐Care Biosensing Platform With Self‐Calibration for Rapid Matrix‐Resistant Detection of Multiple AMI Biomarkers in Whole Blood},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {30},
  doi = {10.1002/adhm.71408}
}
Kostenlos starten →